Lopes Gde L - Search Results

1

Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma.

Haaland B, Chopra A, Acharyya S, Fay AP, Lopes Gde L. Haaland B, et al. Among authors: lopes gde l. BMC Cancer. 2014 Aug 15;14:592. doi: 10.1186/1471-2407-14-592. BMC Cancer. 2014. PMID: 25127891 Free PMC article.

2

Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity.

Ku GY, Chopra A, Lopes Gde L Jr. Ku GY, et al. Among authors: lopes gde l jr. Lung Cancer. 2010 Nov;70(2):223-5. doi: 10.1016/j.lungcan.2010.08.012. Lung Cancer. 2010. PMID: 20817304

3

Pemetrexed in the treatment of thoracic malignancies: a single centre experience in Singapore.

Lopes G, Chopra A, Kukutschka J, Portillo P, Bharwani L, Chang A. Lopes G, et al. Singapore Med J. 2011 Mar;52(3):190-4. Singapore Med J. 2011. PMID: 21451928 Free article.

4

Cost-Effectiveness of Cabozantinib in the Second-Line Treatment of Advanced Hepatocellular Carcinoma.

Soto-Perez-de-Celis E, Aguiar PN, Cordón ML, Chavarri-Guerra Y, Lopes GL. Soto-Perez-de-Celis E, et al. J Natl Compr Canc Netw. 2019 Jun 1;17(6):669-675. doi: 10.6004/jnccn.2018.7275. J Natl Compr Canc Netw. 2019. PMID: 31200357

5

VEGF-A levels in bevacizumab-treated breast cancer patients: a systematic review and meta-analysis.

Santos LV, Cruz MR, Lopes Gde L, Lima JP. Santos LV, et al. Among authors: lopes gde l. Breast Cancer Res Treat. 2015 Jun;151(3):481-9. doi: 10.1007/s10549-015-3410-7. Epub 2015 May 7. Breast Cancer Res Treat. 2015. PMID: 25947646 Review.

6

Cost-effectiveness of pembrolizumab versus chemotherapy as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in the USA.

Huang M, Lopes GL, Insinga RP, Burke T, Ejzykowicz F, Zhang Y, Feliciano JL. Huang M, et al. Immunotherapy. 2019 Dec;11(17):1463-1478. doi: 10.2217/imt-2019-0178. Epub 2019 Nov 18. Immunotherapy. 2019. PMID: 31738117 Clinical Trial.

7

Definitive chemoradiotherapy for squamous head and neck cancer: cisplatin versus carboplatin? A meta-analysis.

Aguiar PN Jr, Tadokoro H, da Silva GF, Landgraf MM, Noia Barreto CM, Filardi BA, Lopes GL Jr, Oliveira P, de Mello RA. Aguiar PN Jr, et al. Future Oncol. 2016 Dec;12(23):2755-2764. doi: 10.2217/fon-2016-0068. Epub 2016 Aug 23. Future Oncol. 2016. PMID: 27549331 Review.

8

Cost effectiveness of chemohormonal therapy in patients with metastatic hormone-sensitive and non-metastatic high-risk prostate cancer.

Aguiar PN Jr, Barreto CMN, Gutierres BS, Tadokoro H, Lopes GL Jr. Aguiar PN Jr, et al. Einstein (Sao Paulo). 2017 Jul-Sep;15(3):349-354. doi: 10.1590/S1679-45082017GS4017. Einstein (Sao Paulo). 2017. PMID: 29091159 Free PMC article.

9

Perspectives in Lung Cancer--Third Asian-pacific Conference. 11-12 September 2009, Bangkok, Thailand.

Lopes Gde L Jr. Lopes Gde L Jr. IDrugs. 2009 Nov;12(11):689-91. IDrugs. 2009. PMID: 19844853

10

How uncommon are isolated lung metastases in colorectal cancer? A review from database of 754 patients over 4 years.

Tan KK, Lopes Gde L Jr, Sim R. Tan KK, et al. Among authors: lopes gde l jr. J Gastrointest Surg. 2009 Apr;13(4):642-8. doi: 10.1007/s11605-008-0757-7. Epub 2008 Dec 11. J Gastrointest Surg. 2009. PMID: 19082673

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters